Crystal tombstone marking the sale of a royalty for cancer drug Zejula. (22AKL516)
These custom designs highlight deal toys within the healthcare space, but also include vial embedments for drug launches, and commemoratives for FDA approval milestones, therapeutic studies, in-human testing, and other industry landmarks.
Crystal tombstone marking the sale of a royalty for cancer drug Zejula. (22AKL516)
Crystal deal toy marking the acquisition of a royalty interest in global sales of pegcetacoplan, marketed under the brand names Empaveli and Aspavell. The drugs were developed for treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH), a rare blood disorder. (22AKL517)
Crystal deal toy celebrating a funding round for behavioral health company Forge Health. Based in White Plains, New York, Forge provides outpatient mental health and substance abuse treatment. (22AZH166)
Lucite tombstone marking the acquisition of Galbraith Laboratories. Based in Knoxville, Tennessee, the company provides testing services to a number of sectors including healthcare, chemicals, and cosmetics. (22AJH131)
Lucite tombstone recognizing the acquisition of GeneTx BioTherapeutics. GeneTx has focused on a therapy for Angelman syndrome, a rare neurogenic disease. (22ALJ280)
Custom financial tombstone recognizing a direct offering of common stock by Salarius Pharmaceuticals. The Houston-based firm develops cancer therapies. (22AJH070)
Lucite deal toy recognizing the acquisition of Cincinnati-based Advanced Testing Laboratory. ATL provides research and development services in such areas as life science, product safety, and analytical chemistry. (22AJH077)
Crystal deal toy marking the sale of Bova Holdings to Vimian Group’s Specialty Pharma division. Bova is the UK’s largest companion animal pharmaceutical company, serving veterinary clinics and animal hospitals.
(22AKL092)Lucite deal toy celebrating a license option agreement between Ironwood Pharmaceuticals and COUR, a biotech firm. The agreement centers on COUR’s therapy for PBC, a rare autoimmune disease affecting the liver.
(22ALJ081)Deal toys in the healthcare and pharmaceutical space reflect a broad range of financial transactions. These deals involve an array of industry players, including drug companies, hospital chains, medtech firms, manufacturers of medical devices, developers of diagnostic equipment, senior living facilities, pharmacies, and testing laboratories, as well as healthcare-focused funds and venture capital firms.
The transactions themselves include mergers and acquisitions, initial public offerings, bond issues, financings, private placements, and early-stage funding rounds.
But also represented here are transactions more unique to the sector, such as drug licensing, royalty, and commercialization agreements.
The custom designs in these galleries also celebrate non-financial industry achievements and milestones. You will see here, for instance, commemoratives involving submissions and approvals from the Food & Drug Administration (FDA) and European Medicines Agency (EMA), therapeutic studies, joint ventures, successful preclinical and in-human testing stages, and product launches.
These milestones can be commemorated with designs incorporating items unique to the specific event, achievement, or innovation being recognized. These design options include, for example, Lucite embedments of actual drug vials and medical devices.
You’ll also find here commemoratives for a variety of other sector-related events. These include custom awards and gifts honoring speakers and attendees at national and international health summits and medical conferences.
"*" indicates required fields
